Market Research Blog – Page 3843 – New Product Development

Global Demand for 3,3-Dimethylacrylic Acid Methyl Ester Soars as Chemical Industry Expands, Predicting a Steady 4.2% Growth According to Future Market Insights

By the end of 2033, the global market for 3,3-dimethylacrylic acid methyl ester is expected to grow at a moderate CAGR and reach a market size of USD 52,327.8 thousand. The increasing demand for 3,3-dimethylacrylic acid methyl ester from the pharmaceutical industry, combined with its expanded use as a synthesis material for organic compounds in chemical industries, is expected to drive the market over the forecast period.

Certain prominent players in the 3,3-Dimethylacrylic Acid Methyl Ester market are focusing on increasing their production capacity by producing the compound at pilot scales. Manufacturers are also working on strengthening their supply chain network and establishing relationships with end users to provide 3,3-Dimethylacrylic Acid Methyl Ester by contract manufacturing in order to boost their income.

The market is dominated by Chinese businesses because the majority of market participants are based in China and provide the product on a contract basis.

Aside from the aforementioned sector trends, the market is also significantly driven by macroeconomic, demographic, innovation, and sustainability considerations. Based on these factors, large investments are being made in the industry, which is projected to increase demand for 3,3-dimethylacrylic acid methyl ester throughout the forecast period.

Get an overview of market drivers and challenges affecting this industry! https://www.futuremarketinsights.com/reports/sample/rep-gb-15077

“The 3,3-dimethylacrylic acid methyl ester market is still in its preliminary phase where the production is led by CMOs (Contract Manufacturing Organizations). With expanding applications of this chemical, its market is expected to thrive through the forecast period.,”says an FMI analyst.

Key Takeaways in 3,3-Dimethylacrylic Acid Methyl Ester Market:

The global market of 3,3-dimethylacrylic acid methyl ester is projected to witness a CAGR of magnitude of 2% during the period of 2023 and 2033.
East Asia and North America will be the key region posing high growth prospects for the market owing to the high production and growing demand for the chemical in this region.
By Purity, >98% pure 3,3-dimethylacrylic acid methyl ester is expected to remain a prominent segment accounting for ~85-90% of the overall market.
By Application, the chemical reagent is the key application consuming about 65% of the global production. The segment is anticipated to grow with a 4.1% CAGR in the forecast period.

Competitive Landscape in 3,3-Dimethylacrylic Acid Methyl Ester Market

The 3,3-dimethylacrylic acid methyl ester market is believed to be an emerging market that is still in its initial development. A few players are analyzed to dominate the market holding about 45% of the market share.

A few of these players are

WeylChem International GmbH
Qingdao Bangli Chemcial Co., Ltd.
Shandong Xinhua Pharma
Hefei TNJ Chemical Industry Co., Ltd.
Gansu Zeyou New Material Co., Ltd.
Dayang chem (Hangzhou) Co., Ltd.
Hunan Huateng Pharmaceutical Co., Ltd
Vortex Product limited
Spectrum chemical mfg. corp.
Innopharm chem
TCI Chemicals India Pvt. Ltd.
Synerzine, Inc.

Multiple key manufacturers are investing significantly in technological development, and product innovations to cater to the growing demand from the end-use industries and to remain competitive in the global market. The market is still in its infancy and certain players are manufacturing the compound at a pilot scale.

For instance, In June 2021, Hangzhou Longshine Bio-Tech Co., Ltd started supplying 3,3 Dimethyl acrylic acid methyl ester also known as Isopentenyl acid methyl ester for making piroctone olamine, pharmaceuticals intermediates, and chemical products.

Interested in Procuring the Data? Inquire here: https://www.futuremarketinsights.com/ask-question/rep-gb-15077

Segmentation of 3,3-Dimethylacrylic Acid Methyl Ester Industry Research

By Purity:

< 98%
> 98%

By Application:

Pharmaceuticals
Chemical Reagent
Flavouring Agent
Others

By Region:

North America
Latin America
Western Europe
Eastern Europe
East Asia
South Asia and the Pacific
Russia & Belarus
Middle East and Africa

More Insights into the 3,3-dimethyl acrylic acid methyl ester Market Report

In its latest report, Future Market Insights offers an unbiased analysis of the global 3,3-dimethylacrylic acid methyl ester market, providing historical data from 2018 to 2022 and forecast statistics for the period 2023 to 2033. To understand the global market potential, growth, and scope, the market is segmented based on purity, application, and region.

About FMI – Chemicals and Materials

The Chemicals and Materials division of FMI offers a distinct and pinpoint analysis of the chemicals and materials industry. This exhaustive coverage extends from commodity, bulk, specialty, and petrochemicals to advanced materials, composites, and nanotechnology in particular, with special emphasis on ‘green alternatives, recycling and renewable technology developments, and supply-demand-trade assessment. Our research studies serve as referencing market guidelines for chemical manufacturers, research institutions, channel partners, and government bodies for developing – ‘The Way Forward’.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Surging Demand for Mild Surfactants Propels Global Amine Oxide Market Growth, Fueled by Personal Care and Home Cleaning Industries

The amine oxide market is poised for growth due to the rising demand for high-performing and sustainable solutions across various industries. Amine oxides are surfactant compounds widely used in personal care products, household cleaners, and industrial applications. With their excellent foaming, emulsifying, and conditioning properties, amine oxides contribute to enhanced performance and product quality.

Amine oxides are the amphoteric surfactants that are widely used in conjunction with various other surfactants. These surfactants can either be cationic (positively charged), anionic (negatively charged) or non-ionic (no charge) depending on the pH of the water. Amine oxides are the chemical compounds that are the only oxides of the tertiary amines. Amine oxides are sometimes also used for the analogous derivation of the primary and secondary amines. Amine oxides are usually used as the protecting group for amines as well as other chemical intermediates.

Amine oxides are high polar molecules and have their polarity close to that of quaternary ammonium salts. However, smaller amines oxides exhibits hydrophilic properties owing to which it is highly soluble in water. Amine oxides find their applications in various industries such as oilfield chemicals, agriculture adjuvants, home care and personal care.

Get our Sample Report to discover how recent industry developments, like: https://www.futuremarketinsights.com/reports/sample/rep-gb-338

The increase in the demand for the mild surfactants especially from the personal care industry is expected to drive the global amine oxide market. The personal care products containing amine oxide offer improved performance even at high temperature in the hard water. Amine oxides are also widely used in the home cleaning products. Amine oxides are used as thickeners, emollients, emulsifiers, stabilizers and conditioners. Amine oxide is a surface active agent which is used to change the surface tension of water that helps in increasing the wetting surfaces, emulsifying, foaming and also assists in cleansing. Thus, the growing demand for the home cleaning products is expected to augment the overall growth of the amine oxide market. Amine oxides are slowly finding its foothold in agricultural adjuvants and oil field chemicals. Owing to the versatility of the amine oxides to work under varying temperature and pressure the there is an increase in the use of this chemical in other applications as well.

The growing population especially in the Asia Pacific is expected to drive the demand for the personal care and home care industry which in turn is expected to boost the overall growth of the amine oxide market. The growing demand for the use of sulfur free as well as the milder personal care products is expected to boost the overall growth of the amine oxide market. Amine oxide is considered as a high production volume class of compounds in many member countries of the Organization for Economic Co-operation and Development (OECD). North America is expected to be one of the major consumers ofamine oxide as it is one of the essential chemical used in most of the widely used home cleaning products. The U.S is one of the largest manufacturers of amine oxide followed by Europe. Japan is one of the major manufacturers of amine oxide in Asia Pacific. China is expected to emerge as the major producer as well as consumer in the coming few years.

Air Products and Chemicals, Inc., BASF, Akzonobel N.V., Stepan Company, Pilot Chemical, Solvay, The Lubrizol Corporation, Lonza Company, Huntsman Corporation and Clariant Corporation are some of the key participants of the global amine oxide market. The companies are mainly focused towards developing new innovative products that would be used extensively in a wide range of applications. Thus, the companies make huge investments in the research and development in order to manufacture innovative and specific product for specific application.

Interested in Procure The Data? Inquire here: https://www.futuremarketinsights.com/ask-question/rep-gb-338

This research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data and statistically-supported and industry-validated market data and projections with a suitable set of assumptions and methodology. It provides analysis and information by categories such as market segments, regions, product types and distribution channels.

Amine Oxide Market Key Segments

By Type:

Non-Ionic Surfactants
1-Dodecanamine
1-Tetradecanamine
Decanamine
Hexadecanamine
Octodecanamine
Others

By Application:

Consumer Products
Agrochemicals
Industrial Chemicals
Coatings
Others

By Region:

North America
Latin America
Asia Pacific
Europe
MEA

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Surging Global Demand Propels Deicing Fluid Market to Projected US$ 8.8 Billion by 2032, Fueled by Growing Aviation Sector and Strategic Partnerships

The global deicing fluid market size was worth US$ 5.3 Billion in the year 2022 and is expected to reach US$ 8.8 Billion by the year 2032 at a CAGR of 5% between 2022 and 2032. Deicing fluids come across as critical chemicals used in the aviation vertical in cold climates around the world. Growing demand for such fluids is accelerating the deicing fluid market.

They are categorized as Type I, Type II, Type III, and Type Iv on the basis of their composition and chemicals, and physical qualities. This could be credited to growing awareness about the product, continued expansion of the aviation sector, increasing freight carrying through airways, and rising number of strategic partnerships. Both – governments and private sectors are extending support to the deicing fluid market for having the aviation vertical in shape.

Deicing fluids constitute glycols, salts, and alcohol. They do reduce water’s freezing point. Mechanical deicing procedures constitute pressing and scraping. Deicing solution gets sprayed on the surface using spray guns or hoses. The region’s meteorological conditions do determine the need for deicing fluid. It is, in fact, directly proportional to an increase in tourism in cold climates.

Technology is actually the flagbearer of deicing operations. All the airlines and airports do spend on cutting-edge technology in aplomb; which actually helps in having superlative deicing operations in place. These days, new techniques are being doled out with regard to reusing the deicing fluid.

Get an overview of market drivers and challenges affecting this industry! https://www.futuremarketinsights.com/reports/sample/rep-gb-326

At the same time, the fact that deicing fluids do induce corrosion and also cause damage to the applied surfaces can’t be ignored. Plus, several low-cost substitutes like heating and mechanical scraping are being made available. These factors could restrain the deicing fluid market in the years to come.

Future Market Insights has walked through these facts with future prospects in its latest market study entitled ‘Deicing Fluid Market’. It has an indigenous team of analysts and consultants to deploy a 360-degree view in primary, secondary, and tertiary modes of research.

“With the aviation industry witnessing a boom in North America, the deicing fluid market is expected to witness grandeur in the upcoming period”, – Future Market Insights.

Key Takeaways from Deicing Fluid Market

North America holds the largest market share due to the US being subject to exorbitant aircraft movements and passenger traffic in the last few years. The region is, in fact, known for housing some of the busiest airports all through. As such, there is a robust demand for quick and effective deicing technologies. Moreover, as the US witnesses blizzard weather conditions at regular intervals, icing on the surface of aircraft is a common phenomenon. January 2018 alone witnessed the US airlines annulling over 1100 flights and grounding of over 3000 planes. The airlines and airports in North America are trying to mitigate such situations by handsomely investing in de-icing systems as well as infrastructure for minimizing discomfort and delays with respect to the customers.
Europe holds the second-largest market share with various economies of Eurasia providing notable development opportunities for the vertical.

Key Companies Profiled

The Dow Chemical Company
Kilfrost
E. I. du Pont de Nemours and Company
Henan Allrich Chemical Co., Ltd.
Cre Chem Qingdao Limited
Weifang Qiangyuan Chemical Industry Co., Ltd.

Interested in Procure The Data? Inquire here: https://www.futuremarketinsights.com/customization-available/rep-gb-326

Competitive Fluid

Aero Mag, in December 2020, came up with the very first electrically-powered truck with the intention of deicing the aircraft.
Invercon Inc., in January 2020, did announce that their deicing system had been successfully tested at NASA Glenn Research Center’s Icing Research Tunnel. This announcement came along with NEI Corporation.
Hartsfield-Jackson Atlanta International Airport, in 2018, did announce its plan of building a south deicing facility worth US$ 50 Million for reducing flight cancellations at the time of snowstorms. It could accommodate merely 5 large planes initially but can deice close to 20 planes at a time now.

Key Segments Profiled in the Deicing Fluid Industry Survey

Type:

Ethylene Glycol
Propylene Glycol

Application:

Commercial
Non-Commercial

Region:

North America
Latin America
Western Europe
Eastern Europe
APEJ
Japan
Middle East & Africa

What does the Report delve deep into?

The research study is based on type (ethylene glycol and polypropylene glycol), and by application (commercial and non-commercial).
With aviation vertical flourishing, there would be nothing to stop the deicing fluid market from substantiating in the forecast period.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Chlorinated Polyethylene Resins and Elastomers (CPE) Market Surges: Projected to Hit US$ 1,297 Million by 2032, Fueled by Robust Growth in Impact Modification Applications and Advancements in Building and Construction Sector

Geomembranes are amongst the major applications of chlorinated resins and elastomers. They could be used as impact modifiers as well as flexible sheeting for roofing membranes, automotives, molded shapes, cable jacketing, and extruded profiles, and ultimately as a base polymer. It needs to be noted that impact modification is the biggest application of chlorinated polyethylene resins and elastomers, as far as consumption is concerned. It is used to impact modify PVC for vinyl sliding, pipes, window profiles, deck, and fence.

The global chlorinated polyethylene resins and elastomers (CPE) market size stands at US$ 600 million as of now and is expected to reach US$ 1.30 Billion by the year 2032 at a CAGR of 8% from 2022 to 2032.

The other advantages are inclusive of exceptional physical and mechanical properties, tensile strength, higher filler acceptance, and low-temperature performance. PVC is being increasingly used for PVS siding, doors, pipes, and fences with upgradation in building and construction sector.

At the same time, the fact that prices of raw materials are volatile can’t be ignored. Also, prices of crude oil are skyrocketing. Polyethylene is made from the crude oil derivatives. As such, it gets directly affected by the factors mentioned above. Also, various economies are laying down strict regulations regarding the use of polyethylene in the interest of environment. These factors are likely to restrain the chlorinated polyethylene resins and elastomers (CPE) market in the near future. Future Market Insights has, through its line of expertise in the form of analysts and consultants, highlighted these findings with future perspectives in its latest market study entitled “Chlorinated Polyethylene Resins and Elastomers (CPE) Market”.

Get an overview of market drivers and challenges affecting this industry: https://www.futuremarketinsights.com/reports/sample/rep-gb-318

Key Takeaways from Chlorinated Polyethylene Resins and Elastomers (CPE) Market

North America is going steady with respect to chlorinated polyethylene resins and elastomers (CPE) market. This could be attributed to excessive usage of PVC in wires, tubing, coatings, cables, and molded products. Personal care products like eyeliners, eyebrow pencils, eye shadows, lipstick, mascara, foundations, and likewise also use PVC.
Europe is expected to witness a CAGR of 12% in the chlorinated polyethylene resins and elastomers (CPE) market on the grounds of the fact that the EU is handsomely investing in pharmaceutical sector. Also, processed food vertical is poised to witness an immense growth herein.
The Asia-Pacific is led by China as it is the largest consumer of chlorinated polyethylene resins and elastomers (CPE) for hoses applications and impact modifiers. On the whole, the construction and electrical verticals are driving the flexible sheeting vertical.

“Impact modification is expected to expedite the chlorinated polyethylene resins and elastomers (CPE) market”, says an analyst from Future Market Insights.

Competitive Landscape

Dow, Inc., in October 2021, entered into partnership with Haldor Topsoe A/S with the objective of efficiently converting waste plastics to the circular plastics, thereby reclaiming their value.
ES-IJ series from Sundow is an exclusive type of polyester-based thermoplastic polyurethane elastomer. The basic application areas encompass injection molding products. The features include fast molding, proper flexibility, higher transparency and resilience, proper abrasion resistance, good hand feeling and texture, and explicit mechanical properties.
Lianda, since the last 2.5 decades, has been providing specialty polymers and performance chemicals to the markets dealing in plastics, adhesives, and elastomers. These specialty polymers comprise FKM (fluoroelastomers), CSM (chlorosulfonated polyethylene), CR (polychloroprene), EPDM, CO/ECO (epichlorohydrin, and likewise.

Interested in Procure The Data? Inquire here: https://www.futuremarketinsights.com/ask-question/rep-gb-318

What does the Report Cover?

Future Market Insights offers an exclusive perspective and various real-time insights on the chlorinated polyethylene resins and elastomers (CPE) market in its latest study, presenting historical demand assessment of 2016 – 2021 and projections for 2022 – 2032.
The research study is based on type (solution chlorination, water suspension, and solid phase chlorination process of stirring bed), by application (automotive, roofing membranes, molded straps, extruded profiles, cable jacketing, and likewise).

Key Segments Covered in the Chlorinated Polyethylene Resins Report

Type:

Solution Chlorination
Water Suspension
Solid Phase Chlorination Process of Stirring Bed

Application:

Automotive
Roofing Membranes
Molded Straps
Extruded Profiles
Cable Jacketing
Others

Region:

North America
Latin America
Western Europe
Eastern Europe
APEJ
Japan
Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Conductive Plastics Market Set to Soar to US$ 7.91 Billion by 2032 with 8.5% Annual Growth, Fueled by Innovation and Sustainability in the Electrical and Electronics Sector

The global conductive plastics market size will reach US$ 7.91 billion by 2032, an 8.5% annual growth rate over the next ten years! The key to success in this industry is innovation and sustainability – two things that are at their core tasks necessary ingredients when it comes down to making products like electronics or electric cars effective without compromising on quality performance

The Electrical and electronics sector plays a pivotal role in the conductive plastics market, driving global demand through continuous innovation and substantial investments by leading manufacturers. The market is poised for substantial growth, fueled by the increasing adoption of personal electronic devices. Conductive plastics are materials that allow electricity to pass through them. These types of plastic, which can be categorized into a variety such as polyamide or propylene glycols involve carbon fibers and stainless steel in their manufacturing process for better conductivity than other less-effective alternatives available on the market today

The major driver behind this industry’s growth comes from increasing demand within electronics while also being used extensively across automotive sectors like cell phone cases among others.

Get our Sample Report to discover how recent industry developments, like: https://www.futuremarketinsights.com/reports/sample/rep-gb-317

Key Takeaways in the Conductive Plastics Market

The demand for conductive plastics is on the rise, and it’s no surprise why. These materials can be used in nearly every industry due to their versatility – they offer benefits like increased efficiency or lower maintenance costs that are invaluable when you’re running a business! Polyamide with its ability resist corrosion from saltwater will also become more popular as we move forward into an era where our oceans play host too much seafood being caught each day.
The electronics industry is a major manufacturer of conductive plastics. The market for these materials has been growing at an alarming rate due to increasing demand from the production line of electronic components such as displays, solar cells and batteries among others that require them for construction purposes or else would fail prematurely because they lack electricity.
Asia-Pacific dominated the Conductive Plastics Market in 2022, owing to the increasing demand for conductive plastics from the electronics and automotive sectors from the region

Important Questions Answered in the Conductive Plastics Market Report

How will the Conductive Plastics market expand through 2032?
Which region is the most lucrative in the Conductive Plastics market?
What are the recent technological developments in the Conductive Plastics market?
What are key challenges and competition threats faced by Conductive Plastics market players?
Who are prominent players leading the Conductive Plastics market?

Conductive Plastics Market: Competitive Evaluation

The FMI’s Conductive Plastics market report provides a comprehensive analysis on key players operating in the Conductive Plastics market. Some of the key players are:

Asbury Carbons
Bekaert Co.
BASF
Electriplast Corporation
Ensinger
Goodrich Corporation
Nanocyl
RTP Co.

With a detailed analysis on the positioning of top companies across the globe, emerging players, strategic players and innovators, the FMI’s study presents the strengths, weaknesses, growth prospects and challenges of key players over the forecast period.

Interested in Procure The Data? Inquire here! https://www.futuremarketinsights.com/ask-question/rep-gb-317

Key Segments Covered in the Conductive Plastics Market Report

Conduction Mechanism:

Conducting Polymer Composites
- ABS Conductive Polymer Composites
- PC Conducting Polymer Composites
- PVC Conducting Polymer Composites
- PP Conducting Polymer Composites
- Nylon Conducting Polymer Composites
- Other Conductive Polymer Composites
Inherently Conductive Polymers
- Polyaniline (PANI)
- Polypyrrole (PPy)
- Polyphenylene Vinylenes (PPV)
- PEDOT
- Other Inherently Conductive Polymers

By Application:

Anti-Static Packaging & Coating
Capacitors
Actuators & Sensors
Batteries
Solar Cells
Electroluminescence
Printed Circuit Board (PCB)
Other Applications

Why Buy FMI’s Report?

Extensive analysis on high growth niche markets across major regions
Detailed assessment on key segments and sub-segments
Recent and upcoming strategies tracked of manufacturers for the Conductive Plastics market
Reliable information on new product launches, technological advancements, and more
Valuable insights on the impact of regulatory framework on the global Conductive Plastics market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Global Age Related Vision Dysfunction Industry Eyes Robust 3.7% CAGR, Targets US$ 130 Billion Milestone by 2033 | FMI

A recent study conducted by Future Market Insights (FMI) has shed light on the optimistic trajectory of the Global Age-Related Vision Dysfunction Industry. The report anticipates a robust Compound Annual Growth Rate (CAGR) of 3.7% from 2023 to 2033, culminating in a market valuation of US$130 Billion by the end of the assessment period.

One of the key drivers fueling the market’s expansion is the escalating incidence of visual impairment and blindness worldwide. The study underlines the critical role played by these factors in propelling the growth of the age-related vision dysfunction market on a global scale.

Moreover, the prevalence of various eye-related ailments, including diabetic eye diseases, glaucoma, cataracts, and age-related macular degeneration, is on the rise. This surge in eye disorders is anticipated to drive the demand for assistive technology in age-related vision dysfunction, further contributing to the market’s growth.

According to a United Nations (UN) estimate, the worldwide population of people aged 60 and more was around 962 million in 2017, with a projected increase to 2.1 billion by 2050 According to the National Federation of the Blind, an estimated 3,171,100 persons aged 65 and older in the United States had visual impairment in 2016. All these factors are likely to drive the age-related vision dysfunction market during the forecast period

Request a Sample Copy of the Report
https://www.futuremarketinsights.com/reports/sample/rep-gb-16212

Key Takeaways from the Global Age Related Vision Dysfunction Industry Study

FMI projects the global Age Related Vision Dysfunction market to expand at a 3.7% value CAGR by 2033
The global Age Related Vision Dysfunction market is estimated at a market value of US$ 90 Billion
The global Age Related Vision Dysfunction market is expected to garner a market value of US$ 130 Billion
As per Future Market Insights, Asia Pacific is expected to grow at a CAGR of 3.5% in the assessment period 2023-2033.
As per Future Market Insights, North America is expected to grow at a CAGR of 3.6% in the assessment period 2023-2033.
As per Future Market Insights, Europe is expected to grow at a CAGR of 3.3% in the assessment period 2023-2033.
The glaucoma segment is expected to hold the largest market share for Age-Related Vision Dysfunction in the forecast period 2023-2033

“Increased government measures to develop assistive technology and supply assistive technology equipment to the disabled is also predicted to fuel growth in the worldwide age related vision dysfunction market.”Says an analyst at FMI

Global Age Related Vision Dysfunction Industry Competition

Aerie Pharmaceuticals
Santen Pharmaceutical
Sun Pharma Advanced Research Company Limited
Bausch + Lomb
D Western Therapeutics Institute
Novartis
AbbVie
Eyenovia
Orasis Pharmaceuticals
IVERIC Bio

Speak to our Research Expert
https://www.futuremarketinsights.com/ask-question/rep-gb-16212

Recent Developments in the Global Age Related Vision Dysfunction Industry:

In May 2020, AbbVie Inc. finalised the strategic acquisition of Allergan plc. As a result of this purchase, AbbVie Inc. has positioned itself as a market leader in the age related vision dysfunction

Key Segments Profiled in the Global Age Related Vision Dysfunction Industry Survey

Global Age Related Vision Dysfunction Industry by Dysfunction Type:

Cataract
AMD
Glaucoma
Presbyopia

Global Age Related Vision Dysfunction Industry by Drug:

Rocklatan
Eybelis Ophthalmic Solution
Xelpros
Rhopressa
Vyzulta
Glanatec
Simbrinza
Tapcom/DE-111
Azarga/Azorga
Combigan
Lucentis
Eylea
Beovu

Global Age Related Vision Dysfunction Industry by Region:

North America
Latin America
Europe
Asia Pacific
Middle East & Africa

Visit for Customization
https://www.futuremarketinsights.com/customization-available/rep-gb-16212

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Chronic Obstructive Pulmonary Disease (COPD) Industry Set to Exceed US$ 33.19 Billion by 2033, Fueled by a Steady 4.4% Annual Growth | Reports FMI

The Global Chronic Obstructive Pulmonary Disease (COPD) Industry is on the brink of significant growth, with a projected value of US$ 21.58 billion in 2023. A comprehensive study by Future Market Insights Inc. foresees a remarkable surge in demand, fueled by the escalating prevalence of alcohol use worldwide. The market is anticipated to experience a steady compound annual growth rate (CAGR) of 4.4% between 2023 and 2033, ultimately reaching an estimated valuation of US$ 33.19 billion by 2033.

The findings of the study underscore the critical impact of evolving lifestyle patterns, with alcohol consumption emerging as a key contributor to the escalating demand for Chronic Obstructive Pulmonary Disorder (COPD) treatments. The research indicates that the rising prevalence of COPD, exacerbated by increased alcohol use, is a primary driver behind the anticipated market expansion over the next decade.

Request a Sample PDF Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-16215

Additionally, the World Health Organization (WHO) states that the most common cause of COPD is exposure to tobacco smoke both via first-hand as well as second-hand smoking. This global increase in the prevalence of COPD is a major factor fueling the growth of the COPD market in the forthcoming years. In addition, the rise in consumption of tobacco among millennials, coupled with the rise in the awareness among the population, regarding the use of generic drugs are projected to contribute to the revenue share of the chronic obstructive pulmonary disease market shortly.

According to the Centers for Disease Control and Prevention (CDCP), the cost related to COPD in the US was 32.1 $ billion in 2010 and rose to 49 billion by 2020. Hence, the continual growth witnessed in the cases of COPD among the population worldwide is a major factor that will intensify the growth of the COPD market over the forecast period.

Key Takeaways from the Global Chronic Obstructive Pulmonary Disease (COPD) Industry Study

The global Chronic Obstructive Pulmonary Disease (COPD) Market was valued at US$ 20.67 Billion by 2022-end
From 2018 to 2022, the market demand expanded at a CAGR of 2.4%
By Type, the Chronic Bronchitis segment of the market constitutes the bulk of the market with a market share of 43%
By Distribution Channel, the Retail Pharmacies segment dominates the market with a share of 42%
From 2023 to 2033, Chronic Obstructive Pulmonary Disease (COPD) sales are expected to flourish at a CAGR of 4.4%.
By 2033, the market value of Chronic Obstructive Pulmonary Disease (COPD) is expected to reach US$ 33.19 Billion.

Contact us for Discount
https://www.futuremarketinsights.com/request-discount/rep-gb-16215

The continual increase in cases of COPD globally, coupled with rising cases of tobacco consumers are the major factors escalating the growth of the Chronic Obstructive Pulmonary Disease (COPD) market shortly, remarks an FMI analyst.

Global Chronic Obstructive Pulmonary Disease (COPD) Industry Competitive Landscape

Prominent players in the Chronic Obstructive Pulmonary Disease (COPD) market are Almirall, AstraZeneca, Boehringer Ingelheim International GmbH, CHIESI Farmaceutici S.p.A., F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc., Kyowa Hakko Kirin, Mylan N.V., Novartis AG, Orion Corporation, Sanofi, Sunovion Pharmaceuticals, Inc. (Sumitomo Dainippon Pharma Co., Ltd.), Teva Pharmaceutical Industries Ltd., Theravance Biopharma, and Verona Pharmaceuticals, among others.

Recent Developments In the Global Chronic Obstructive Pulmonary Disease (COPD) Industry:

In June 2022, Verona Pharma, a pharmaceutical company, announced the completion of the patient enrolment, with more than 800 subjects involved in its randomized ENHANCE-1 trial. The study will evaluate ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease. It is a critical step for the phase III ENHANCE trial with top-line data expected by the end of the year 2022 and further data from ENHANCE-2 in the third quarter of 2022.
In May 2022, Alembic Pharmaceuticals Ltd, a pharmaceutical company, received final approval from the US health regulator for its generic version of Arformoterol Tartrate inhalation solution indicated for long-term treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease. The approval by the U.S. Food & Drug Administration (USFDA) for the abbreviated new drug application (ANDA) for Arformoterol Tartrate inhalation solution is for the strength of 15 mcg (base)/2 mL unit-dose vial.

Know More About What the Global Chronic Obstructive Pulmonary Disease (COPD) Industry Report Covers

Future Market Insights offers an unbiased analysis of the global Chronic Obstructive Pulmonary Disease (COPD) Market, providing historical data for 2018 to 2022 and forecast statistics from 2023 to 2033. To understand opportunities in the Chronic Obstructive Pulmonary Disease (COPD) Market, the market is segmented based on drug class, type, and distribution channel, across five major regions.

Visit for Customization
https://www.futuremarketinsights.com/customization-available/rep-gb-16215

Key Segments Covered in the Global Chronic Obstructive Pulmonary Disease (COPD) Industry Analysis

Global Chronic Obstructive Pulmonary Disease (COPD) Industry by Drug Class:

Combination Therapy
Bronchodilators
Corticosteroids
Phosphodiesterase Type 4 Inhibitor
Mucokinetics
Others

Global Chronic Obstructive Pulmonary Disease (COPD) Industry by Type:

Chronic Bronchitis
Emphysema

Global Chronic Obstructive Pulmonary Disease (COPD) Industry by Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Chronic Obstructive Pulmonary Disease (COPD) Industry by Region:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Global IgA Nephropathy Industry Poised to Attain US$ 85 Billion Valuation by 2033, Driven by a Resilient 7.5% CAGR | FMI Insights

The Global IgA Nephropathy Industry is set to experience substantial growth, with Future Market Insights (FMI) forecasting a remarkable 7.5% Compound Annual Growth Rate (CAGR) during the forecast period from 2023 to 2033. The global market for IgA nephropathy is expected to reach a staggering US$ 85 Billion by the year 2033.

This optimistic outlook is underpinned by several key factors identified in the comprehensive analysis conducted by FMI. The high prevalence of kidney diseases, coupled with a surge in research and development activities, increasing investments from market players, and continuous technological innovations, is anticipated to be the driving force behind the robust market growth.

One of the pivotal factors contributing to the projected market expansion is the growing number of initiatives taken by governments globally. Various governmental efforts aimed at providing facilities, such as reimbursement for diagnostic tests, are expected to play a significant role in boosting the Global IgA Nephropathy Industry.

Request for a sample Copy:
https://www.futuremarketinsights.com/reports/sample/rep-gb-16217

The COVID-19 pandemic has been associated with an increase in hospitalization and infection hotspots around the country. There were at least three separate waves of COVID-19 around the world by June 2021 that put a significant strain on hospital resources, especially labor, and the availability of dialysis equipment & supplies. In addition, the COVID-19 pandemic has affected healthcare services for renal disease patients. Social distancing and lockdown were mandate norms, globally, leading to the temporary closure of other medical services. The diagnosis of several renal diseases was deferred during the pandemic due to the suspension of non-urgent visits and testing services.

On the other hand, increasing awareness regarding IgA nephropathy is expected to create lucrative opportunities for market growth. For instance, In the U.S., an estimated 37 million adults have kidney disease. Major risk factors for the disease are high blood pressure and diabetes as well as heart disease, obesity, & family history of kidney disease. In addition, North America and Asia Pacific are two major regions contributing to the IgA nephropathy market.

Key Takeaways from the Global IgA Nephropathy Industry Study

IgA Nephropathy market to garner US$ 85 Billion by the end of 2033.
IgA Nephropathy market to register a positive CAGR of 7.5% in the forecast period 2023-2033
By end user, the hospital’s segment is expected to hold 40% of the market share in 2023 for IgA nephropathy market.
By diagnosis, the urine tests segment is projected to witness significant a CAGR of 7.5% during the forecast years.
North America is expected to possess 40% market share for IgA nephropathy market in 2023.
Asia Pacific is expected to hold 35% market share for IgA nephropathy market share in 2023.

Inquire Before Buying Research Report:
https://www.futuremarketinsights.com/ask-question/rep-gb-16217

“Growing prevalence of kidney related problems along with research and development for manufacturing medication is favoring the growth of IgA nephropathy market” states a FMI analyst

Global IgA Nephropathy Industry Competitive Landscape

Some of the key companies in the IgA Nephropathy market include Calliditas Therapeutics AB, Travere Therapeutics, Inc., Omeros Corporation, Novartis Pharmaceuticals, Chinook Therapeutics, Inc., Vera Therapeutics, Inc., Otsuka Pharmaceutical, and others

In June 2021, Novartis Pharmaceuticals announced iptacopan met Phase II study primary endpoint in rare kidney disease IgA nephropathy (IgAN).
Chinook Therapeutics, Inc., a key player in the IgA nephropathy market is focusing on diagnosing the causes of the ailment and offering customized and specific treatments based on the same.

Key Segments Profiled in the Global IgA Nephropathy Industry Survey

Diagnosis:

Iothalamate Clearance Test
Kidney Biopsy
Blood Tests
Urine Tests

Diseases Type:

Primary IgA Nephropathy
Secondary IgA Nephropathy

Systems:

Hematuria
Proteinuria
Edema
Others

Population Type:

Pediatrics
Adults

Route of Administration:

Oral
Parenteral
Others

Buy This Report:
https://www.futuremarketinsights.com/checkout/16217

Treatment:

Medication
Statin therapy
Omega-3 fatty acids
Angiotensin-converting enzyme (ACE) inhibitors
Angiotensin receptor blockers (ARBs)
Diuretics
Immunosuppressants
Kidney Transplantation
Others

End Users:

Hospitals
Specialty Clinics
Homecare
Others

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Global Human Immunodeficiency Virus Type 1 (HIV-1) Industry to Surpass US$ 62 Billion by 2033, Growing at a Steady 6% CAGR | FMI

The Global Human Immunodeficiency Virus Type 1 (HIV-1) Industry is anticipated to achieve a remarkable valuation of US$ 34.83 billion in 2023, marking a significant milestone in the fight against HIV/AIDS. This projection is backed by a compound annual growth rate (CAGR) of 6%, expected to persist from 2023 to 2033, according to a comprehensive study conducted by the Institute for Health Metrics and Evaluation.

The steady growth in the industry is primarily attributed to the persistent rise in the incidence rate of HIV-1 infections globally. Despite progress in treatment options, the number of new cases continues to climb, affecting approximately 37 million individuals worldwide. Intriguingly, the mortality rate associated with HIV-1 has not witnessed a significant change over time, emphasizing the critical need for advanced therapeutic interventions.

Currently, only half of the affected population has access to antiretroviral therapeutic interventions for disease management. This underscores a substantial gap in treatment accessibility that the healthcare industry aims to address over the forecasted decade.

Request a Sample of this Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-16202

Because of the large percentage of HIV patients in highly populous countries such as China and India, the Asia Pacific market is expected to become the fastest-growing market with the highest CAGR over the coming years. Furthermore, the massive amount of therapeutic interventions, as well as monetary support from corporate companies and medical companies, are anticipated to propel the industry forward.

Key Takeaways from the Global Human Immunodeficiency Virus Type 1 (HIV-1) Industry Study

North America led the market in 2022, with a sales volume of US$ 21 Billion.
According to a study conducted by the Centers for Disease Control (CDC) in 2021, an estimated 1.2 million people had HIV at the end of 2018.
Based on the World Health Organization (WHO), approximately 33.0 million people will be infected with HIV by 2021.
Women and girls comprised 54% of all HIV-positive people, according to the WHO.
From 2018 to 2022, sales increased significantly at a CAGR of 1.6%.

Ask the Analyst:
https://www.futuremarketinsights.com/ask-question/rep-gb-16202

Global Human Immunodeficiency Virus Type 1 (HIV-1) Industry Players

Key players in the Human Immunodeficiency Virus Type 1 (HIV 1) market are AbbVie, Inc., Boehringer, and Ingelheim GmbH. Bristol-Myers Squibb Company, Cipla, Inc., Genentech, Inc., Gilead Sciences, Inc., Merck & Co., Inc., ViiV Healthcare, GlaxoSmithKline, Sanofi.

In July 2021 – Unitaid and the Clinton Health Access Initiative, Inc. (CHAI) announced a pricing agreement with the medical company Hetero Labs LTD to make darunavir plus ritonavir (DRV/r) available as a second-line treatment for HIV patients in low and middle-income countries for US$ 210 per patient/year.
In March 2021, Gilead Sciences Inc. and Merck announced a collaboration agreement to co-develop and co-commercialize long-term HIV treatment. The investigational capsid inhibitor lenacapavir from Gilead and the investigational nucleoside reverse transcriptase translocation inhibitor islatravir from Merck will be paired to form a two-drug HIV regimen.
On January 20, 2021 – HIV ViiV Healthcare evolved Cabenuva, an injectable drug approved by the US Food and Drug Administration for the treatment of human immunodeficiency virus type 1 (HIV) infections in adults.

Request for Customization:
https://www.futuremarketinsights.com/customization-available/rep-gb-16202

Key Segments Profiled in the Global Human Immunodeficiency Virus Type 1 (HIV-1) Industry Survey

Global Human Immunodeficiency Virus Type 1 (HIV-1) Industry by Drug Class:

Nucleoside-Analog Reverse Transcriptase Inhibitor
Non-Nucleoside Reverse Transcriptase Inhibitor
Entry and Fusion Inhibitors
Protease Inhibitors
Integrase Inhibitors
Coreceptor Antagonists

Global Human Immunodeficiency Virus Type 1 (HIV-1) Industry by Region:

North America
Europe
Asia Pacific
Latin America
Middle East and Africa (MEA)

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Global Pancreatic Cancer Industry Ready to Hit US$ 7,541.09 Million by 2033 with a Noteworthy CAGR of 13.5% | FMI

In a groundbreaking revelation, Future Market Insights Inc. A renowned healthcare analysis firm has released a comprehensive analysis of the Global Pancreatic Cancer Industry, projecting a valuation of approximately US$ 2,125.57 Million by the end of 2023. The study anticipates an extraordinary Compound Annual Growth Rate (CAGR) of 13.5%, laying the foundation for a significant leap to surpass US$ 7,541.09 Million by 2033.

Pancreatic cancer, a disease with profound implications, has emerged as one of the most prevalent forms of cancer worldwide. Alarming statistics reveal that it ranks as the seventh leading cause of cancer-related fatalities globally, underscoring the urgency of addressing this critical healthcare challenge.

The analysis further highlights a notable upward trend in the prevalence of pancreatic cancer, particularly in the Western world. Of concern is the rise in cases of pancreatic adenocarcinoma within developed regions. Lifestyle factors, including alcohol consumption and obesity, are believed to be substantial contributors to this worrisome trend.

Request a Sample Copy of This Report Now.
https://www.futuremarketinsights.com/reports/sample/rep-gb-16183

Why Choose Future Market Insights

Serving domestic and international clients 24/7
Prompt and efficient customer service
Data collected from reliable primary and secondary sources
Highly trained and experienced team of research analysts
Seamless delivery of tailor-made market research reports

Global Pancreatic Cancer Industry: Segmentation

Valuable information covered in the FMI’s Pancreatic Cancer market report has been segregated into key segments and sub-segments.

By Treatment Type:

Chemotherapy
Immunotherapy
Hormone Therapy
Surgery
Radiation Therapy
Targeted Drug Therapy
Others

Grab Your Discount Now Before It’s Gone!
https://www.futuremarketinsights.com/request-discount/rep-gb-16183

By Cancer Type:

Endocrine Pancreatic Cancer
Exocrine Pancreatic Cancer

By End User:

Hospitals
Clinics
Diagnostic Laboratories
Research Institutes
Research Laboratories
Others

Global Pancreatic Cancer Industry: Competition Analysis

The FMI’s study presents a comprehensive analysis of global, regional, and country-level players active in the Global Pancreatic Cancer Industry. Competitive information detailed in the Pancreatic Cancer market report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player. Furthermore, growth strategies and mergers & acquisitions (M&A) activities associated with the players are enclosed in the Global Pancreatic Cancer Industry report.

Key players covered in the report include:

Pfizer Inc.
Novartis AG
Eli Lily and Company
Bristol Myers Squibb Company
Zydus Cadila
Myriad Genetics Inc.
F-Hoffmann-La Roche Ltd.
PharmaCyte Biotech Inc.
Teva Pharmaceutical Industries Ltd.

Get Your Customized Impactful Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-16183

Important Questions Answered in the Global Pancreatic Cancer Industry Report

Which end-user remains the top revenue contributor in different regional markets?
At what rate has the global Global Pancreatic Cancer Industry been expanding during the forecast period?
How will the global Pancreatic Cancer market look like by the end of the forecast period?
What innovative strategies are adopted by Global Pancreatic Cancer Industry players to stay ahead of the pack?
What are the restraints affecting the growth of the global Pancreatic Cancer market?

Key Offerings of the Report

Growth Drivers and Opportunities: Comprehensive analysis of growth-driving factors and opportunities for market players in different regional markets
Recent Trends and Forecasts: Detailed assessment of the latest trends, technological developments, and forecasts for a 5-year or 10-year period.
Segmental Analysis: Extensive analysis of each segment and factors differentiating the role of these segments in market revenue forecasts and growth rate analysis
Regional Market Forecast: Thorough analysis of each regional market to arm stakeholders with the necessary information to make critical decisions
Competitive Landscape: All-inclusive insights on both leading and emerging players vying for a slice of the Global Pancreatic Cancer Industry

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani